Kaiser Health News, L.A. Times Discuss Possibility Of Revoked Approval Of Breast Canc
 

Some advocacy groups and lawmakers are urging FDA not to revoke its approval of Roche's Avastin for treatment of advanced breast cancer, arguing that such a decision would limit women's access to the drug by prompting insurers to reject coverage for it, the Fiscal Times/Kaiser Health News reports...

More...